COMPANY

Tides Medical

Location: Lafayette, LA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Diabetic Foot Ulcer Lower Extremity Chronic Ulcers in Diabetics Chronic Foot Ulcers Venous Ulcer

Timeline

Nov 14, 2024 Trial start Not phased (device or behavioral study): Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers source ↗
Mar 3, 2023 Trial start Not phased (device or behavioral study): Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers. source ↗
2016-09 Trial start Not phased (device or behavioral study): Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers source ↗

Nov 18, 2026 (ESTIMATED) · Not phased · Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers · NCT06681428

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07219004	Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.	Not phased (device or behavioral study)	Completed	Mar 3, 2023	Sep 27, 2023 (actual)
NCT06681428	Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers	Not phased (device or behavioral study)	Recruiting	Nov 14, 2024	Nov 18, 2026 (estimated)
NCT02838784	Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers	Not phased (device or behavioral study)	Unknown status (ClinicalTrials.gov)	2016-09	2018-12 (estimated)